Plus Therapeutics Inc. (PSTV) PT Raised to $5.25 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Price: $3.87 --0%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on Plus Therapeutics Inc. (NASDAQ: PSTV) to $5.25 (from $5.00) while maintaining a Buy rating.
You May Also Be Interested In
- Cerenome Reports Second Quarter 2026 Financial Results and Business Update
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
